# Does Carnosine reduce inflammaging in pediatric obesity?

Canonical source: https://retacompare.com/research/does-carnosine-reduce-inflammaging-in-pediatric-obesity

Peptide Longevity Q&A · 2026-03-14


    Research indicates that Carnosine levels are reduced in the visceral adipose tissue of children with obesity, suggesting a link to heightened inflammation and mitochondrial stress. This reduction may contribute to chronic low-grade inflammation, a factor associated with aging and metabolic disorders.

What the research shows

The study published in the Journal of Clinical Lipidology focused on pediatric obesity and aimed to identify depot-specific metabolic alterations in adipose tissue. Researchers collected adipose tissue samples from 30 children, including 12 with overweight/obesity and 18 of normal weight. Using untargeted metabolomics, they analyzed polar metabolites in both subcutaneous (sWAT) and visceral (vWAT) white adipose tissue. The findings revealed significant differences in metabolite profiles between the two groups, particularly in vWAT, where 24 metabolites were altered compared to normal-weight controls. Notably, the study highlighted imbalances in amino acids, including reduced levels of Carnosine, which were associated with increased mitochondrial stress and inflammation.

Why it matters for longevity

The reduction of Carnosine in visceral adipose tissue may have implications for longevity, particularly concerning chronic low-grade inflammation, also known as inflammaging. Inflammation is a critical factor in the development of various age-related diseases, including metabolic disorders, cardiovascular diseases, and neurodegenerative conditions. The study's findings suggest that addressing the metabolic alterations associated with obesity could be vital in reducing inflammation and improving overall health outcomes. By understanding how Carnosine levels relate to inflammation and metabolic health, researchers may identify potential therapeutic strategies to enhance longevity and healthspan.

Key findings at a glance

Children with obesity showed reduced Carnosine levels in visceral adipose tissue.

Visceral adipose tissue exhibited 24 significantly altered metabolites compared to normal-weight controls.

Elevated levels of ketone bodies and amino acids were observed in the vWAT of children with obesity.

Reduced Carnosine levels may indicate heightened mitochondrial stress and inflammation.

Subcutaneous adipose tissue showed fewer metabolic variations in children with obesity.

How Carnosine works (background)

Carnosine is a dipeptide composed of beta-alanine and histidine, known for its antioxidant properties and potential role in cellular health. It is believed to help buffer pH levels in muscles, protect against oxidative stress, and modulate inflammatory responses. Carnosine may also play a role in mitochondrial function, which is crucial for energy metabolism. The reduction of Carnosine in visceral adipose tissue, as noted in this study, may impair these protective mechanisms, contributing to the inflammatory state observed in obesity.

Safety, caveats, and what we don't yet know

While the findings provide insights into the relationship between Carnosine levels and inflammation in pediatric obesity, there are limitations to consider. The study's sample size was relatively small, and its findings may not be generalizable to broader populations. Additionally, the research primarily focused on children, leaving gaps in understanding how these metabolic alterations manifest in adults or older populations. Further studies are needed to explore the long-term effects of Carnosine supplementation and its potential role in reducing inflammation across different age groups.

Bottom line

The reduction of Carnosine in visceral adipose tissue among children with obesity suggests a possible link to increased inflammation and metabolic stress. This finding underscores the importance of understanding Carnosine's role in combating chronic low-grade inflammation, which may have implications for longevity.

Related questions

Can Carnosine improve metabolic health in older adults?

Research indicates that Carnosine may have roles in improving metabolic health, particularly through its antioxidant properties and effects on inflammation. However, specific studies focusing on older adults are needed to clarify its efficacy in this population.

What role does Carnosine play in muscle aging?

Carnosine is known to support muscle function and may help mitigate age-related muscle decline. Its antioxidant properties could protect against oxidative stress, a key factor in muscle aging, but more research is required to confirm these effects.

How does Carnosine affect mitochondrial function?

Carnosine is believed to play a role in maintaining mitochondrial health by buffering pH levels and reducing oxidative stress. However, further studies are necessary to fully understand its mechanisms and potential benefits for mitochondrial function in aging.

Source: PubMed · J Clin Lipidol · published 2026-03-14.

## Sources

- PubMed · J Clin Lipidol: https://pubmed.ncbi.nlm.nih.gov/41963120/